The shelf life of Russia-developed Sputnik V vaccine against coronavirus has been extended to 18 months, according to the state register of medicines. The extension applies to both components of the Sputnik V vaccine produced by the …
The Gamaleya Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have announced the development of another version of the Sputnik V coronavirus vaccine, tailored to combat the Delta and Omicron …
The study showed that the vaccine is 97% effective when boosted with Sputnik Light or revaccinated with Sputnik V in cases of hospitalisation from the COVID-19 strain. A team of Russian scientists, including specialists from the …
Argentina’s Richmond company continues to prepare for a full-cycle production of the Russian Sputnik V vaccine, the Clarin newspaper reported. Its source, commenting on the situation around the full-cycle production of Sputnik V …
The World Health Organization (WHO) scheduled to visit Russia on March 7 to assess the facilities regarding the Russian application for the inclusion of the Sputnik V vaccine in the list of drugs recommended for emergency use in a pandemic. …
Preliminary results from an additional study of the Sputnik V vaccine have shown that inoculated volunteers retained a fairly high level of antibodies one year after the first jab, the Moscow mayor's official website reported on Thursday. …
Experts from the World Health Organization (WHO) are going to visit Russia in February to inspect the production sites of the Sputnik V vaccine against the new coronavirus. This was reported in the press service of the Russian Ministry of Health …
\Experts from the World Health Organization (WHO) are expected to visit Russia for a verification inspection of the Sputnik V coronavirus vaccine in the coming month, Alexander Gintsburg, director of the Gamaleya Center, the vaccine’s …
Italy’s opposition center-right Brothers of Italy party addressed the government asking to recognize the Russian Sputnik V vaccine for the issuance of COVID certificates, a statement by lawmakers Lucia Albano and Riccardo Zucconi said. …
The antibodies of over 70% of those inoculated with the Russian Sputnik V vaccine retain their neutralizing activity against the Omicron strain and in the majority of cases it is retained even 3-6 months following vaccination, a research and …
Russia has passed to the World Health Organization (WHO) all data on the Sputnik V coronavirus vaccine. A visit by experts to inspect the production sites is expected in February, Minister of Health Mikhail Murashko said during his working trip …
The Russian Sputnik V COVID-19 vaccine’s efficacy against the Omicron variant stands at about 75%, Director of the Gamaleya Research Institute of Epidemiology and Microbiology Alexander Gintsburg said on Tuesday. "In total, …
The European Medicines Agency (EMA) experts have positively evaluated production standards for Sputnik V COVID-19 vaccine, deputy head of the Gamaleya Research Centre Denis Logunov said on Tuesday. "Regarding how the production …
The Sputnik nasal coronavirus vaccine will be supplied to the market in the first quarter of 2022, the Russian vaccine’s Twitter account said on Wednesday, citing the Gamaleya Scientific Research Institute of Epidemiology and …
Kazakhstan plans to ship 150,000 doses of the Sputnik Light vaccine in late December this year or early January next year, says Aizhan Yesmagambetova, chief sanitary official of the Kazakh Health Ministry. "There is an agreement …
The World Health Organization (WHO) plans to organize an inspection in Russia in February 2022 as part of the procedure of approving Russia’s Sputnik V coronavirus vaccine for emergency use, Rogerio Gaspar, Director of the WHO Regulation …
The Russian Sputnik V COVID-19 vaccine is likely to be supplied to African countries free of charge, CEO of the Russian Direct Investment Fund Kirill Dmitriev told the Rossiya-1 TV channel on Sunday. "The first batches are likely …
Russia's Sputnik V vaccine provides a strong defence against serious symptoms and hospitalisations caused by the Omicron coronavirus variant, the RDIF sovereign wealth fund said on Friday, citing a preliminary study by the vaccine …
Initial data on the effectiveness of the Sputnik V vaccine against the Omicron strain may be obtained as early as next week, Director of the Gamaleya National Research Center for Epidemiology and Microbiology Alexander Gintsburg told the …
Russia has not yet provided part of information required for the certification of its Sputnik V jab against the coronavirus by the World Health Organization (WHO) due to inconsistency in standards, but the process is underway, Kremlin Spokesman …
